Richard M Myers

USPTO Granted Patents = 13 (Patent Applications = 11)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 3)

Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 12(Granted Patents)

Location History:

Stanford, CA (US) (2002 - 2016)
Paradise, CA (US) (2016)
Provo, UT (US) (2021)
Huntsville, AL (US) (2019 - 2023)

Company Filing History:

7 out of 5,307

Leland Stanford Junior University

patents

6 out of 7

Hudsonalpha Institute for Biotechnology

patents

1 out of 581

The Uab Research Foundation

patents

4. 3 out of 832,718

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2024

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12157759 - Method of treating breast cancer (2024-12-03),

2. 11781176 - Method for blocking miRNA (2023-10-10),

3. 11566291 - Differential methylation level of CpG loci that are determinative of a biochemical reoccurrence of prostate cancer (2023-01-31),

4. 11085088 - Method of treating prostate cancer (2021-08-10),

5. 10989623 - Leaking tank testing device (2021-04-27),

6. 10501804 - Differential methylation level of CPG loci that are determinative of a biochemical reoccurrence of prostate cancer (2019-12-10),

7. 10480023 - Method for blocking miRNA (2019-11-19),

8. 9272230 - Oil extraction device for use at home and method of use (2016-03-01),

9. 9234242 - Methods for treating depression using NCAM peptide mimetics (2016-01-12),

10. 8415298 - Administration of FGF2 for treamtent of anxiety (2013-04-09),

11. 7687235 - Compositions and methods for diagnosing and treating neuropsychiatric disorders (2010-03-30),

12. 7410759 - Compositions and methods for diagnosing and treating mood disorders (2008-08-12),

13. 6432635 - Cystatin B mutants (2002-08-13),

Title: Richard M. Myers: Innovator in Cancer Research

Introduction

Richard M. Myers is a prominent inventor based in Stanford, California, known for his significant contributions to cancer research. With a total of 13 patents to his name, he has developed innovative methods and compositions that aim to improve the detection and treatment of breast cancer and other malignancies.

Latest Patents

Among his latest patents is a method of treating breast cancer, which provides novel fusion proteins and polypeptides expressed by breast cancer and other cancer cells. This patent outlines compositions, materials, and methods for detecting, characterizing, and treating breast and other cancers. In one embodiment, the fusion polypeptides are read-through fusion transcripts. Another notable patent is a method for blocking micro-RNA (miRNA), which includes reducing the abundance of a non-target miRNA that is part of a group of miRNAs. This method involves annealing a complementary region of a blocking nucleic acid to a binding site at the first end of the unwanted miRNA, ligating an adenylated nucleic acid adapter to the group of miRNAs, and performing RT-PCR on the group of miRNAs. Kits and compounds for use with this method are also provided.

Career Highlights

Richard has worked with esteemed institutions such as Leland Stanford Junior University and HudsonAlpha Institute for Biotechnology. His work has significantly advanced the field of cancer research, particularly in the development of targeted therapies.

Collaborations

Richard has collaborated with notable colleagues, including Huda Akil and Stanley Watson, contributing to a rich environment of innovation and research.

Conclusion

Richard M. Myers stands out as a key figure in the realm of cancer research, with his innovative patents paving the way for new treatment methodologies. His dedication to improving patient outcomes through scientific advancements is commendable.

This text is generated by artificial intelligence and may not be accurate.